In an ambitious move to strengthen its healthcare manufacturing base, the Haryana government is crafting a new policy designed to attract around ₹5,000 crore into pharmaceuticals and medical device production across the state.
Under the proposed Pharmaceutical and Medical Device Manufacturing Policy, the state plans to offer a mix of fiscal and non-fiscal incentives to businesses that set up new units or scale up existing operations. Key measures on the table include support for capital expenses (with amounts up to ₹200 crore) and operational expenditure support up to ₹20 crore. Startups will also benefit: those working in the pharma or medtech sector may be eligible for reimbursement of up to 50% of prototype development costs, capped at ₹10 lakh annually.
The policy aims not just to manufacture, but to build a full ecosystem. It envisions fostering research & development, incubator infrastructure, and specialised pharmaceutical or medical device clusters and parks. Other focal points are export promotion, securing international certifications for products, and creating linkages for global supply chains.
A senior government official from the industry department explained that the policy seeks several goals: reducing Haryana’s dependence on imports, ensuring availability of affordable medicines and medical devices locally, and broadly revamping the state’s medtech sector by encouraging innovation, jobs, and value-chain completeness.
(Source: TNN)